Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • ESMA Announces Open Hearing On Market Abuse

    Date 08/09/2014

    The European Securities and Markets Authority (ESMA) will hold an open hearing on the issues raised in the two recently published Consultation papers on draft Technical Standards and  on possible implementing measures on the Market Abuse Regulation.

  • SGX, UniSIM Investor Education Day On 13 Sep

    Date 08/09/2014

    Singapore Exchange (SGX) and SIM University (UniSIM) will hold their first-ever jointly organised Investor Education Day on 13 September 2014.

  • The Most Advanced Trading Platform Just Got Better - Horizon Launches New Version Of Its Trading Technology

    Date 08/09/2014

    Horizon Software, the provider of the most advanced algorithmic trading technology on the market, today announced the latest version of its electronic trading platform. The newly-launched v2.1 significantly increases the throughput, reduces platform latency and extends its potential by covering all the business needs of equity and equity derivatives desks (Delta One, Options trading, customer flow, etc.). The new version provides a host of compliance tools, which will now allow clients to meet market-making obligations anywhere in the world and includes regulatory safeguards such as anti-self-matching, short-sell tagging and throttling limitations.

  • SGX: Singapore Fixed Income Indices (SFI) Weekly

    Date 08/09/2014

    Below are key highlights for the week ending 5 September 2014 (please click on the attachment for further detail):

  • AQX° Securities Speaks Out Against ESMA’s Proposed Ban On Research Commission In MiFID II - AQX° Letter To ESMA Says Proposed Approach Will Negatively Impact EU Firms’ Competitive Edge

    Date 08/09/2014

    AQX° Securities, the service-oriented, multi-asset, execution services provider, today spoke out against ESMA’s proposal for a ban on research commission in MiFID II. In a letter sent to ESMA on 30 July 2014, AQX set out its counter-arguments, stating its disagreement to the  independent EU Authority’s proposal for investment managers to be limited to accepting minor, non-monetary benefits and clearly citing the benefits to the investor of greater choice of research from a growing pool of providers. AQX also argued that ESMA’s proposed approach will impact competition between EU firms and their ability to compete further afield.